These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563 [TBL] [Abstract][Full Text] [Related]
7. Epilepsy in TSC: certain etiology does not mean certain prognosis. Vignoli A; La Briola F; Turner K; Scornavacca G; Chiesa V; Zambrelli E; Piazzini A; Savini MN; Alfano RM; Canevini MP Epilepsia; 2013 Dec; 54(12):2134-42. PubMed ID: 24304436 [TBL] [Abstract][Full Text] [Related]
11. Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan. Mizuguchi M; Ikeda H; Kagitani-Shimono K; Yoshinaga H; Suzuki Y; Aoki M; Endo M; Yonemura M; Kubota M Brain Dev; 2019 Jan; 41(1):1-10. PubMed ID: 30060984 [TBL] [Abstract][Full Text] [Related]
12. Ictal signs in tuberous sclerosis complex: Clinical and video-EEG features in a large series of recorded seizures. Savini MN; Mingarelli A; Vignoli A; La Briola F; Chiesa V; Peron A; Mai R; Tassi L; Mastrangelo M; Zambrelli E; Turner K; Canevini MP Epilepsy Behav; 2018 Aug; 85():14-20. PubMed ID: 29906696 [TBL] [Abstract][Full Text] [Related]
13. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex. Friedman D; Bogner M; Parker-Menzer K; Devinsky O Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947 [TBL] [Abstract][Full Text] [Related]
14. Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option? Wiegand G; May TW; Ostertag P; Boor R; Stephani U; Franz DN Eur J Paediatr Neurol; 2013 Nov; 17(6):631-8. PubMed ID: 23845174 [TBL] [Abstract][Full Text] [Related]
15. Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex. Okanishi T; Akiyama T; Tanaka S; Mayo E; Mitsutake A; Boelman C; Go C; Snead OC; Drake J; Rutka J; Ochi A; Otsubo H Epilepsia; 2014 Oct; 55(10):1602-10. PubMed ID: 25196064 [TBL] [Abstract][Full Text] [Related]
16. Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex. Ma TS; Elliott RE; Ruppe V; Devinsky O; Kuzniecky R; Weiner HL; Carlson C J Neurosurg Pediatr; 2012 Nov; 10(5):376-82. PubMed ID: 22998031 [TBL] [Abstract][Full Text] [Related]
17. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Chu-Shore CJ; Major P; Montenegro M; Thiele E Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694 [TBL] [Abstract][Full Text] [Related]
18. The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex. Huang CH; Peng SS; Weng WC; Su YN; Lee WT; J Formos Med Assoc; 2015 Sep; 114(9):849-54. PubMed ID: 24698169 [TBL] [Abstract][Full Text] [Related]
19. White matter disruption is associated with persistent seizures in tuberous sclerosis complex. Moavero R; Napolitano A; Cusmai R; Vigevano F; Figà-Talamanca L; Calbi G; Curatolo P; Bernardi B Epilepsy Behav; 2016 Jul; 60():63-67. PubMed ID: 27179194 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers. Hamer HM; Pfäfflin M; Baier H; Bösebeck F; Franz M; Holtkamp M; Kurlemann G; May TW; Mayer T; Metzner M; Steinhoff BJ; Stodieck S; Straub HB; Weber YG; Brandt C Epilepsy Behav; 2018 May; 82():64-67. PubMed ID: 29587187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]